Document:

EX-10.2

			
	

	  	Exhibit 10.2

 AMENDMENT NO. 4 TO STRATEGIC SUPPLIER ALLIANCE AGREEMENT 

This Amendment No. 4 (the “Fourth Amendment”) to the certain Strategic Supplier Alliance Agreement dated as of July 7, 2011 (the
“Supplier Agreement”) by and between Repligen Sweden AB, formerly known as Novozymes Biopharma AB, (the “Supplier”) a company organized under the laws of Sweden and a wholly owned subsidiary of Repligen Corporation
(“Repligen”) and GE Healthcare Bio-Sciences AB, a company organized under the laws of Sweden (“GEHC”) is made effective as of the date of last signature (the “Amendment
Effective Date”) with reference to the following: 
 WITNESSETH: 

WHEREAS, the Supplier Agreement has previously been amended three times in accordance with; (1) an amendment made effective as of October 27, 2011
(the “Amendment No. 1”); (2) an amendment made effective February 22, 2013 (the “2013 Amendment”); and (3) an amendment made effective as of February 22, 2016 (the Amendment No. 3), together the
“Previous Amendments”; and 
 WHEREAS, the Previous Amendments and the Supplier Agreement jointly hereinafter the “Agreement” 

WHEREAS, GEHC and Supplier mutually wish to make certain modifications to the terms and conditions of the Agreement 

WHEREAS, Section 18.8 of Attachment E to the Supplier Agreement provides that the Supplier Agreement may be modified only by a writing signed by both
parties. 
 In the event that any terms and conditions contained herein are in conflict with the terms and conditions set forth in the Agreement or
previously executed amendments thereto, the terms and conditions set forth in this Amendment shall be deemed to be the controlling terms and conditions. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and
sufficiency of which are acknowledged, the parties to this Amendment agree as follows: 

  
 Portions of this Exhibit were omitted
and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions. 

Page 1 

 1. Amendment. 
  

	 	a.	Section 1(a) and (iii) of Amendment No. 3 erroneously called the Fourth Amendment. Both references to the “Fourth Amendment” shall be corrected to “Third Amendment.” 

 

	 	b.	The first sentence of Section 3(c), as previously amended by Section 2(c) of Amendment No. 3, is deleted and replaced with the following sentence: 

“GEHC shall settle any undisputed invoices arising under this Agreement [*] after date of invoice prepared in accordance with the terms of
this Agreement.” 
  

	 	c.	The first paragraph of Section 16.1 of Attachment E, as previously amended by Amendment No.1 and Section 2(l) of Amendment No. 3, is amended and replaced in its entirety as follows: 

“This Agreement shall commence on the Effective Date and, subject as hereinafter provided, shall continue in effect until Dec 31st 2019. Notwithstanding the aforementioned, GEHC may reduce its minimum purchase commitments for any or all Products from Supplier hereunder [*] upon [*] written notice to Supplier, provided that GEHC
may not issue such notice of reduction until after [*]. However, in the event GEHC reduces its purchase commitment, what is set out in Section 2g of Amendment No. 3 shall apply accordingly. 

If the Supplier deems that an investment is needed to meet the GEHC volume forecast for 2019, the Supplier shall notify and describe the clear
rationale to GEHC for such an investment before implementation and GEHC shall review the request and send the Supplier GEHC ́s recommendation to the requested investment within [*]. If GEHC express its support to the investment and only in the
case that GEHC thereafter send a notice to the Supplier to reduce the purchase commitment, GEHC will reimburse the Supplier with the verified investments costs but maximum up to the level that was agreed in advance. For avoidance of doubt the GEHC
reimbursement commitment is limited to [*].” 
 2. Ratification. The Agreement as amended hereby is ratified by each of the parties hereto and shall
remain in full force and effect in accordance with its terms as so amended. This Amendment is not a consent to any waiver or modification of any other terms or conditions of the Agreement and shall not prejudice any rights which any of the parties
may now or hereafter have in connection with the Agreement. 
 3. Counterparts. This Amendment may be signed in any number of counterparts, each of which
shall be an original, and all of which taken together shall constitute a single amendment, with the same effect as if the signatures hereto and thereto were upon the same instrument. 

  
 Portions of this Exhibit were omitted
and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions. 

Page 2 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment to the Agreement to be executed by its
duly authorized officer or representative set forth below as of the Amendment Effective Date. 
  

			
	GE Healthcare Bio-Sciences AB	  	Repligen Sweden AB
		
	/s/ Bo Lundström	  	/s/ Tony Hunt
	By (Signature)	  	By (Signature)
		
	Bo Lundström	  	Tony Hunt
	Printed Name	  	Printed Name
		
	Management Director	  	President & CEO
	Title	  	Title
		
	20/2-2018	  	February 12, 2018
	Date	  	Date

  
 Portions of this Exhibit were omitted
and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act; [*] denotes omissions. 

Page 3EX-10.3

 Exhibit 10.3 

REPLIGEN CORPORATION 

AMENDED AND RESTATED 
 NON-EMPLOYEE DIRECTORS’ COMPENSATION POLICY 
 Cash Fees 

Annual Retainer: 
  

					
	 	  	Annual Retainer	 
	 Board of Directors (the “Board”)
	  			
	 Each Non-Employee Member of the Board
	  	$	50,000	 
	 Additional Retainer for the Chairperson
	  	$	90,000	 
		  	  
	  
	 
	 Audit Committee
	  			
	 Committee Chairperson
	  	$	30,000	 
	 Other Committee Members
	  	$	10,000	 
		  	  
	  
	 
	 Compensation Committee
	  			
	 Committee Chairperson
	  	$	20,000	 
	 Other Committee Members
	  	$	10,000	 
		  	  
	  
	 
	 Nominating and Corporate Governance Committee
	  			
	 Committee Chairperson
	  	$	16,000	 
	 Other Committee Members
	  	$	5,000	 
		  	  
	  
	 

 The Annual Retainer will be paid quarterly, in arrears, or upon the earlier resignation or removal of the non-employee director. Amounts owing to non-employee directors as Annual Retainer shall be annualized, meaning that for non-employee
directors who join the Board during the calendar year, such amounts shall be pro rated based on the number of calendar days served by such director. 

Per Meeting fees: 
 None, unless otherwise
specifically duly approved by the Board or any committee thereof hereafter. 
 Equity 

Initial Equity Grant for a Non-Employee Director: 

On the effective date of a new director’s appointment or first election to the Board, such new director shall receive an option to
purchase 24,000 shares of Common Stock on the date he or she joins the Board (the “Initial Award”). The “strike price” for the Initial Award shall be the Closing Price. The Initial Award shall vest annually in three
equal installments on the first, second and third anniversary of the date of grant, provided that if a new director is first elected to the Board at an annual meeting of stockholders, then each vesting date in respect of such Initial Award shall be
on such anniversary of the date of grant or the date of the annual meeting of stockholders during such year, whichever is earlier, subject in all cases to service on the Board on such date. 

 Annual Equity Grant for each Non-Employee Director: 

Each non-employee director reelected to the Board at any annual meeting of stockholders shall receive
an award of a stock option to purchase shares of Common Stock and an award of restricted stock units on such date (collectively, the “Annual Award”). 

The stock option to be granted in the Annual Award (i) to the Chairperson of the Board shall have an aggregate value of $87,500 and
(ii) to all other non-employee directors shall each have an aggregate value of $62,500. The number of shares subject to each such stock option shall be determined by the Company using a Black Scholes
methodology and its customary assumptions therefor. 
 The number of restricted stock units to be granted in the Annual Award (i) to the
Chairperson of the Board shall $87,500 divided by the Closing Price and (ii) to all other non-employee directors shall each be equal to shall be equal to $62,500 divided by the Closing Price. 

Each Annual Award shall be fully vested on the anniversary of the date of grant or the date of the next annual meeting of stockholders,
whichever is earlier, subject to service on the Board on such date. 
 Definitions 

“Closing Price” shall mean the reported closing price of Repligen Corporation’s Common Stock on the Nasdaq Global
Market on any grant date, or the preceding business date if there are no market quotations on such date. 
 “Common
Stock” shall mean the common stock of Repligen Corporation, par value $0.01 per share. 

*        *        * 

ADOPTED BY THE BOARD OF DIRECTORS on March 1, 2018. 

  
 2Exhibit

Exhibit 10.1

FIRST AMENDMENT TO STORAGE SERVICES AGREEMENT – ANACORTES II

This First Amendment to Storage Services Agreement – Anacortes II (this “Amendment”) is dated January 1, 2018, but effective as of November 8, 2017,  by and between Tesoro Logistics Operations LLC, a Delaware limited liability company (“TLO”), and for purposes of  Section 24(a) only, Tesoro Logistics GP, LLC, a Delaware limited liability company (the “General Partner”), and Andeavor Logistics LP, a Delaware limited partnership (the “Partnership”), on the one hand, and Tesoro Refining & Marketing Company LLC, a Delaware limited liability company (“Customer”), on the other hand.

RECITALS    

WHEREAS, the Parties entered into that certain Storage Services Agreement – Anacortes II, dated effective as of the Commencement Date (the “Original Agreement”) pursuant to which TLO provides storage, handling, blending and other services with respect to crude oil, refinery feedstocks and refined products owned by Customer and stored at Storage Facility II, on the terms and conditions set forth therein; and
WHEREAS, the Parties desire to replace Schedule A and Schedule B of the Original Agreement with Schedule A-1 and Schedule B-1 attached hereto, respectively.  
NOW, THEREFORE, in consideration of the covenants and obligations contained herein, the Parties to this Amendment hereby agree as follows:
1.     The Parties hereby agree to delete Schedule A and Schedule B attached to the Original Agreement and replace them in their entirety with Schedule A-1 and Schedule B-1, respectively, attached hereto and incorporated herein by reference.
2.     The Parties hereby confirm and ratify all of the terms and conditions of the Original Agreement, as amended herein, as of the date of execution hereof.  All terms not defined herein shall have the meanings set forth in the Original Agreement.  

[Signature Page Follows]

1

IN WITNESS WHEREOF, the Parties hereto have duly executed this Agreement as of the Commencement Date.

	
		
	TESORO LOGISTICS OPERATIONS LLC

By:  /s/ STEVEN M. STERIN         
Steven M. Sterin
President and Chief Financial Officer

ANDEAVOR LOGISTICS LP
By:   TESORO LOGISTICS GP, LLC,
         its general partner

By:  /s/ STEVEN M. STERIN         
Steven M. Sterin
President and Chief Financial Officer

TESORO LOGISTICS GP, LLC

By:  /s/ STEVEN M. STERIN         
Steven M. Sterin
President and Chief Financial Officer

	TESORO REFINING & MARKETING COMPANY
LLC 

By: /s/ GREGORY J. GOFF            
Gregory J. Goff
President

Schedule A-1 
First Amendment to Storage Services Agreement – Anacortes II

SCHEDULE A-1
Storage Facility
Sixty-six (66) in service crude and black-oil, petroleum product, and chemicals storage tanks with a total deemed shell capacity of approximately 3.9 million Barrels, thirty-five (35) OOS or incidental tanks, a gasoline blending unit, a transfer pump house, and pipelines and other appurtenances that allow the transport of crude oil and petroleum products to and from the nearby dock and to and from other facilities located at the Refinery.  “OOS” designates tanks that are currently out of service. No Shell Capacity will be charged hereunder for OOS or incidental tanks, unless an OOS tank is returned to service.  For purposes of this Agreement, the Shell Capacity of each Tank shall be deemed to be the volume stated on Schedule B-1, regardless of actual capacity of a Tank that might be obtained by on site measurement or other engineering standards.

Schedule A-1 
First Amendment to Storage Services Agreement – Anacortes II

SCHEDULE B-1
TANKS
	
		
	TANK NUMBER
	SHELL CAPACITY (in Barrels)

	1
	139,800

	2
	139,800

	3
	139,800

	4
	140,200

	5
	139,800

	6
	136,800

	7
	136,800

	8
	76,300

	9
	77,300

	10
	51,600

	11
	76,200

	12
	74,200

	13
	60,900

	14
	73,300

	15
	51,600

	16
	51,600

	17
	51,600

	18
	51,600

	19
	11,490

	20
	22,200

	21
	27,800

	22
	27,800

	23
	28,900

	24
	65,600

	25
	28,700

	26
	77,600

	27
	24,400

	28
	27,800

	29
	74,300

	30
	27,800

	31
	27,800

	32
	74,100

	33
	28,300

	34
	OOS

	35
	77,300

	36
	77,300

	37
	10,900

	38
	10,900

    

	
		
	TANK NUMBER
	SHELL CAPACITY (in Barrels)

	45
	281

	46
	OOS

	47
	OOS

	48
	OOS

	53
	952

	54
	952

	55
	OOS

	56
	424

	60
	140,300

	62
	OOS

	88
	OOS

	89
	OOS

	90
	OOS

	91
	27,900

	92
	141,600

	95
	OOS

	98
	OOS

	99
	OOS

	109
	488

	110
	OOS

	113
	27,900

	114
	115,900

	115
	488

	134
	87,800

	138
	281

	142
	142,500

	147
	OOS

	148
	137,300

	156
	NA

	157
	NA

	158
	NA

	159
	OOS

	160
	1,924

	171
	124,700

	180
	NA

	202
	182,800

	203
	182,800

	221
	NA

	222
	NA

	223
	NA

	224
	NA

    

	
		
	TANK NUMBER
	SHELL CAPACITY (in Barrels)

	225
	NA

	226
	NA

	227
	NA

	228
	NA

	229
	NA

	230
	29,900

	231
	101,300

	232
	OOS

	247
	15,600

	248
	16,400

	249
	OOS

	241 A
	NA

	241 B
	NA

	255
	NA

	280
	NA

	801
	896

	802
	896

	803
	896

	804
	896

	866
	713

	867
	713

	877
	NA

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}]]